You have 8 free searches left this month | for more free features.

SAE serious adverse event

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Serious Adverse Event in Emergency Department With dysKAlemia,

Recruiting
  • Emergencies
    • Metz, France
      CHR Metz-Thionville/Hopital de Mercy
    Mar 28, 2023

    Serious Adverse Events Within the AFNET

    Completed
    • Atrial Fibrillation
    • +4 more
      • Brandenburg, Germany
        Staedt. Klinikum, Department of Cardiology
      Sep 18, 2020

      Continuous Monitoring of Vital Signs at Home (WARD HOME II)

      Recruiting
      • Vital Sign Monitoring
      • +2 more
      • Continuously monitoring
      • Copenhagen, NV, Denmark
        Bispebjerg Hospital
      Oct 4, 2023

      GENE SEQUENCING AS A STRATEGY FOR IDENTIFYING GENETIC FACTORS

      Recruiting
      • Covid-19 Vaccination Serious Adverse Events
        • Rio De Janeiro, Brazil
          Unidade de Ensaios Clínicos para Imunobiológicos (UECI)
        Nov 23, 2022

        Healthy Volunteers Trial in Dhaka (ShigETEC live, attenuated, oral vaccine, Placebo)

        Not yet recruiting
        • Healthy Volunteers
        • ShigETEC live, attenuated, oral vaccine
        • Placebo
        • Dhaka, Bangladesh
          International Centre for Diarrhoeal Diseases Research, Banglades
        Aug 3, 2023

        Hand, Foot and Mouth Disease Trial (EV71 Vaccine)

        Not yet recruiting
        • Hand, Foot and Mouth Disease
        • EV71 Vaccine
        • (no location specified)
        Nov 17, 2023

        Athletic Performance Trial in Cornelius (Clinical Investigation on Enhanced Sports Nutrition and Performance Activities by

        Recruiting
        • Athletic Performance
        • Clinical Investigation on Enhanced Sports Nutrition and Performance Activities by Prodovite VMP35 Supplement
        • Broad Spectrum Safety
        • Cornelius, North Carolina
          Champions Sports Performance & Hardcore Serious Fitness
        May 5, 2021

        Viral Infection COVID-19 Trial in Saint Petersburg, (Aterixen)

        Not yet recruiting
        • Viral Infection COVID-19
        • Saint Petersburg,, Russian Federation
          Limited Liability Company "Research Center Eco-Safety"
        Oct 23, 2023

        NSCLC Trial in Guangzhou (PEF, Anti-PD-1 mAb)

        Recruiting
        • NSCLC
        • PEF
        • Anti-PD-1 monoclonal antibody
        • Guangzhou, Guangdong, China
          The first Affiliated Hospital of Guangzhou Medical University
        Aug 3, 2023

        Evaluation of Growth Hormone in Children in China(CGLS)

        Recruiting
        • Childhood Short Stature
        • Polvethylene glycol recombinant human growth hormone injection (PEG-rhGH) or recombinanthuman growth hormone injection (rhGH)
        • Wuhan, Hubei, China
          TongjiHospital
        Oct 31, 2023

        Uncomplicated Plasmodium Falciparum Malaria Trial (KLU156, Coartem)

        Not yet recruiting
        • Uncomplicated Plasmodium Falciparum Malaria
        • (no location specified)
        May 3, 2023

        Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)

        Completed
        • Ebola Virus Disease
        • Ad26.ZEBOV vaccine
        • Boende, Province De La Tshuapa, Congo, The Democratic Republic of the
          Hôpital Général de Référence de Boende
        Jan 3, 2023

        Biosimilars of Rituximab in ANCA-associated Vasculitis Compared

        Recruiting
        • ANCA-associated Vasculitis
        • +2 more
          • Calgary, Alberta, Canada
          • +8 more
          Jan 27, 2023

          Acute Otitis Media (AOM) Trial in Thailand (V114, Pediatric vaccines)

          Active, not recruiting
          • Acute Otitis Media (AOM)
          • V114
          • Pediatric vaccines
          • Bangkok, Krung Thep Maha Nakhon, Thailand
          • +12 more
          Aug 17, 2022

          COVID-19 Trial in Jakarta, Bandung (Standard of Care + Quinine Sulfate, Standard of Care)

          Recruiting
          • COVID-19
          • Standard of Care + Quinine Sulfate
          • Standard of Care
          • Jakarta, DKI Jakarta, Indonesia
          • +1 more
          Apr 10, 2023

          Metastatic Lung Non-Small Cell Carcinoma, EGFR T790M Trial in Seoul (Lazertinib)

          Not yet recruiting
          • Metastatic Lung Non-Small Cell Carcinoma
          • EGFR T790M
          • Seoul, Korea, Republic of
            Samsung Medical Center
          May 18, 2022

          Brain Injury Traumatic Severe (Diagnosis), Coma, Consciousness, Level Altered Trial in Boston (Methylphenidate)

          Recruiting
          • Brain Injury Traumatic Severe (Diagnosis)
          • +3 more
          • Boston, Massachusetts
            Massachusetts General Hospital
          Feb 1, 2022

          COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

          Not yet recruiting
          • COVID-19
          • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
          • Placebo
          • (no location specified)
          Sep 22, 2023

          Intraventricular Hemorrhage of Prematurity Trial (MLT+EPO, Placebo)

          Not yet recruiting
          • Intraventricular Hemorrhage of Prematurity
          • MLT+EPO
          • Placebo
          • (no location specified)
          Jan 5, 2023

          Advanced Solid Tumors Trial in Shanghai, Tianjin (FHND5071)

          Enrolling by invitation
          • Advanced Solid Tumors
          • Shanghai, China
          • +1 more
          Apr 17, 2023

          Advanced Liver Cancer Trial (OH2 injection)

          Not yet recruiting
          • Advanced Liver Cancer
          • OH2 injection
          • (no location specified)
          Jan 29, 2023

          Nesina® Tablet Monotherapy or Combination Therapy in Type 2

          Completed
          • Type 2 Diabetes Mellitus
          • Alogliptin Benzoate
          • Andong, Korea, Republic of
          • +22 more
          Mar 31, 2022

          CNS Tumors Trial in Beijing (OH2 injection)

          Recruiting
          • Central Nervous System Tumors
          • OH2 injection
          • Beijing, Beijing, China
            Beijing Tiantan Hospital, Capital Medical University
          Feb 2, 2023

          Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

          Not yet recruiting
          • Primary Hepatocellular Carcinoma
          • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
          • camrelizumab for Injection
          • (no location specified)
          Nov 13, 2023